Pharmacokinetics of therapeutic tregs

American Journal of Transplantation

Volumn 14, Issue 12, 2014, Pages 2679-2680

  Tang, Q ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RAPAMYCIN; TACROLIMUS; IMMUNOSUPPRESSIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; CELL THERAPY; CONTROLLED STUDY; EDITORIAL; GRAFT REJECTION; NONHUMAN; REGULATORY T LYMPHOCYTE; SPECIES DIFFERENCE; THERAPY EFFECT; ADOPTIVE TRANSFER; ANIMAL; CD4+ T LYMPHOCYTE; IMMUNOLOGY; DRUG SAFETY; HUMAN CELL; PHARMACOKINETICS;

ADOPTIVE TRANSFER; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; IMMUNOSUPPRESSIVE AGENTS; SIROLIMUS; T-LYMPHOCYTES, REGULATORY; TACROLIMUS;

EID: 84910665009     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12933     Document Type: Editorial

References (5)

1. Tang Q, Bluestone JA., Regulatory T-cell therapy in transplantation: Moving to the clinic. Cold Spring Harb Perspect Med 2013; 3: a015552.
2. Singh K, Stempora L, Donald Harvey R, et al. Superiority of rapamycin over tacrolimus in preserving nonhuman primate Treg half-life and phenotype after adoptive transfer. Am J Transplant 2014; 14: 2691-2703.
3. Tang Q, Lee K., Regulatory T-cell therapy for transplantation: How many cells do we need ? Curr Opin Organ Transplant 2012; 17: 349-354.
4. Managh AJ, Edwards SL, Bushell A, et al. Single cell tracking of gadolinium labeled CD4+ T cells by laser ablation inductively coupled plasma mass spectrometry. Anal Chem 2013; 85: 10627-10634.
5. Busch R, Neese RA, Awada M, Hayes GM, Hellerstein MK., Measurement of cell proliferation by heavy water labeling. Nat Protoc 2007; 2: 3045-3057.